BioCryst Pharmaceuticals News

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.

Apr 2 16:27 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT

Mar 4 17:51 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HEGGIE THERESA

Mar 4 16:36 ET

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Felix J. Baker(4.98%),Julian C. Baker(4.98%), etc.

Feb 14 17:47 ET

BioCryst Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)

Feb 14 09:07 ET

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.67%)

Feb 13 18:08 ET

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)

Jan 24 17:32 ET

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.24%)

Jan 24 13:10 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P

Jan 4 00:00 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.

Dec 20, 2023 16:42 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P

Dec 20, 2023 16:40 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K

Dec 20, 2023 16:38 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Doyle Anthony

Dec 20, 2023 16:35 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Barnes Alane P

Dec 20, 2023 16:33 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.

Dec 18, 2023 16:47 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P

Dec 18, 2023 16:43 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K

Dec 18, 2023 16:40 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Doyle Anthony

Dec 18, 2023 16:37 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Barnes Alane P

Dec 18, 2023 16:34 ET

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT

Dec 1, 2023 16:42 ET